$1.400
-0.136 (-9.68%)終値時点
- 高値
- 1.490
- 始値
- 1.475
- 出来高加重平均価格
- 1.42
- 出来高
- 4.90M
- 時価総額
- —
- 安値
- 1.370
- 売買代金
- 6.95M
- EV/EBITDA（TTM）
- 0.00
Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
AI分析 of Qtrex Quantum Ltd (QTEX)
中立QTEX is currently not a strong buy due to its recent significant price drop of 19.79% over the last 5 days, despite a remarkable year-to-date increase of 294.74%. The RSI stands at 53.665, indicating a neutral momentum, while the forward P/E ratio of 8.2508 suggests potential value. However, the risk remains high with a negative net margin of -408.88% in the latest quarter, which could impact future profitability.
バリュエーション指標
イベントタイムライン
ニュース
8.510-19NewsfilterQTREX Quantum Regains Nasdaq Compliance with Minimum Bid Price
- 8.510-14Newsfilter
QTREX Quantum Fully Exercises All Warrants Held by Shareholder
- 8.510-14Newsfilter
QTREX Quantum Announces Clean Capital Structure and High-Density Interconnect Architecture
- 8.510-09Newsfilter
QTREX Shares Recover Above $1 for Six Days
- 9.509-29Newsfilter
NetSol Technologies Reports Strongest Fiscal Year 2026 Results
QTEX のよくある質問 — Alphio AI が回答
Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV. It operates in the Healthcare sector.
QTEX is currently not a strong buy due to its recent significant price drop of 19.79% over the last 5 days, despite a remarkable year-to-date increase of 294.74%. The RSI stands at 53.665, indicating a neutral momentum, while the forward P/E ratio of 8.2508 suggests potential value. However, the risk remains high with a negative net margin of -408.88% in the latest quarter, which could impact future profitability.
コミュニティ
もっと見る ↗投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。